Alzheimer's disease Presenilin 1 Amyloid β precursor protein FLIM (fluorescence lifetime imaging microscopy) Neuronal activity Deposition of amyloid β (Aβ) containing plaques in the brain is one of the neuropathological hallmarks of Alzheimer's disease (AD). It has been suggested that modulation of neuronal activity may alter Aβ production in the brain. We postulate that these changes in Aβ production are due to changes in the rate-limiting step of Aβ generation, APP cleavage by γ-secretase. By combining biochemical approaches with fluorescence lifetime imaging microscopy, we found that neuronal inhibition decreases endogenous APP and PS1 interactions, which correlates with reduced Aβ production. By contrast, neuronal activation had a two-phase effect: it initially enhanced APP-PS1 interaction leading to increased Aβ production, which followed by a decrease in the APP and PS1 proximity/interaction. Accordingly, treatment of neurons with naturally secreted Aβ isolated from AD brain or with synthetic Aβ resulted in reduced APP and PS1 proximity. Moreover, applying low concentration of Aβ 42 to cultured neurons inhibited de novo Aβ synthesis. These data provide evidence that neuronal activity regulates endogenous APP-PS1 interactions, and suggest a model of a product-enzyme negative feedback. Thus, under normal physiological conditions Aβ may impact its own production by modifying γ-secretase cleavage of APP. Disruption of this negative modulation may cause Aβ overproduction leading to neurotoxicity.
Alzheimer's disease (AD) is a progressive neurological disorder of the elderly that is associated with synaptic loss and displays amyloid plaques and neurofibrillary tangles as characteristic pathological hallmarks. The main components of amyloid plaques are Aβ peptides of different lengths generated from the amyloid β precursor protein (APP) by β-secretase and PS1/γ-secretase.
Recent study linked regional differences in neuronal activity and cerebral metabolism with amyloid deposition in the brain of transgenic mice (Bero et al., 2011) ; however, the underlying mechanism remains unclear. It has been suggested that neuronal activity may control APP processing, but reports in the literature how Aβ production is affected provide conflicting results. Studies using slice cultures and cultured cortical neurons show a positive correlation of Aβ secretion with neuronal activity, and suggest that neuronal activation favors cleavage of APP by β-secretase over α-secretase (Hoe et al., 2009; Kamenetz et al., 2003; Lesne et al., 2005) . By contrast, other studies report that stimulation of NMDA receptors in primary cultured neurons inhibits Aβ release, induces trafficking of α-secretase ADAM10 to the postsynaptic membrane, and increases α-secretase mediated APP cleavage within the Aβ region (Marcello et al., 2007) . The role PS1/γ-secretase plays in activity-controlled Aβ generation, however, remains poorly understood. Moreover, although the role of Aβ in Alzheimer's disease pathology is well established, it remains unclear whether Aβ at low, physiological concentrations may have a function in the brain.
Thus, the goal of the present study is to elucidate how neuronal activity affects endogenous Aβ production, to determine if APP and PS1/γ-secretase interaction is involved, and to evaluate whether Aβ may play a regulatory role in its own production. Using biochemical and morphological methods, we found that neuronal activation increases while neuronal inhibition decreases Aβ production and APP-PS1 proximity in primary neurons. Moreover, we show changes Abbreviations: Aβ, amyloid β; APP, amyloid β precursor protein; AD, Alzheimer's disease; BACE1, β-secretase; DIV, days in vitro; FLIM, fluorescence lifetime imaging microscopy; FRET, fluorescence resonance energy transfer; mAb, monoclonal antibody; NDS, normal donkey serum; PS1, presenilin 1; PTX, picrotoxin; TTX, tetrodotoxin; SEC, size exclusion chromatography.
